Trademark: 97219271
Word
NORDIC PHARMA
Status Date
Monday, November 13, 2023
Filing Date
Friday, January 14, 2022
Published for Opposition
Tuesday, October 11, 2022
5 Pharmaceutical preparations for the treatment of gastrointestinal diseases, cardiovascular diseases, pain treatment, anti-infectious diseases, respiratory diseases, diabetes, allergic reactions, Meniere's diseases, diseases associated with the immune system; pharmaceutical preparations for the treatment of gynecological and obstetrical diseases and conditions; pharmaceutical preparations for the treatment of hematological and oncological diseases and conditions
The mark consists of the wording NORDIC above PHARMA in black followed by a vertical green rectangle.
The color(s) black and green is/are claimed as a feature of the mark.
"PHARMA"
Nov 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2023
Sou Extension 2 Granted
Nov 13, 2023
Sou Extension 2 Filed
Nov 13, 2023
Sou Teas Extension Received
May 13, 2023
Notice Of Approval Of Extension Request E-Mailed
May 11, 2023
Sou Extension 1 Granted
May 11, 2023
Sou Extension 1 Filed
May 11, 2023
Sou Teas Extension Received
Dec 6, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 11, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 11, 2022
Published For Opposition
Sep 21, 2022
Notification Of Notice Of Publication E-Mailed
Sep 7, 2022
Approved For Pub - Principal Register
Aug 31, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Correspondence Received In Law Office
Aug 31, 2022
Teas Response To Office Action Received
Aug 30, 2022
Notification Of Non-Final Action E-Mailed
Aug 30, 2022
Non-Final Action E-Mailed
Aug 30, 2022
Non-Final Action Written
Aug 25, 2022
Assigned To Examiner
Jan 21, 2022
Notice Of Design Search Code E-Mailed
Jan 20, 2022
New Application Office Supplied Data Entered
Jan 18, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
